Myocardial Ischemic Events in Patients With Atrial Fibrillation Treated With Dabigatran or Warfarin in the RE-LY (Randomized Evaluation of Long-Term Anticoagulation Therapy) Trial

H. Hohnloser, Stefan; Oldgren, Jonas; Yang, Sean; Wallentin, Lars; Ezekowitz, Michael; Reilly, Paul; Eikelboom, John; Brueckmann, Martina; Yusuf, Salim; J. Connolly, Stuart

doi:10.1161/circulationaha.111.055970

Public

Myocardial Ischemic Events in Patients With Atrial Fibrillation Treated With Dabigatran or Warfarin in the RE-LY (Randomized Evaluation of Long-Term Anticoagulation Therapy) Trial

Shared by NobleBlocks on Feb 7, 2012 • 12:00 AM UTC

Authors:

Stefan H. Hohnloser

Jonas Oldgren

Sean Yang

Abstract

Background— There is a modest risk of myocardial infarction (MI) and myocardial ischemic events in patients with atrial fibrillation. Methods and Results— Data from the RE-LY study (Randomized Evaluation of Long-Term Anticoagulation Therapy) were used to report rates of MI, unstable angina, cardiac ...

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!